Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(14%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
2
29%
Ph phase_4
1
14%
Ph early_phase_1
1
14%
Ph phase_1
2
29%

Phase Distribution

3

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(2)
Other(4)

Detailed Status

unknown3
Completed2
Recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 12 (33.3%)
Phase 32 (33.3%)
Phase 41 (16.7%)

Trials by Status

unknown343%
completed229%
recruiting114%
suspended114%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_1

Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

NCT06414096
completedearly_phase_1

Step Down FSH Approach and Late Follicular Phase in Progesterone Level

NCT03356964
unknownphase_4

Effects of FSH on Endothelial Function (FEND)

NCT04430621
unknownphase_1

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

NCT02179255
suspendedphase_3

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

NCT00749853
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06414096Phase 1

Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome

Recruiting
NCT03356964Early Phase 1

Step Down FSH Approach and Late Follicular Phase in Progesterone Level

Completed
NCT04430621Phase 4

Effects of FSH on Endothelial Function (FEND)

Unknown
NCT02179255Phase 1

Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF

Unknown
NCT00749853Phase 3

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Suspended
NCT00335725Phase 3

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

Completed
NCT01662180

Predicting Ovarian Response in Artificial Insemination With Low Stimulation

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7